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exploration by axillary-thoracotomy remains the procedure of choice 
for patients undergoing pulmonary metastasectomy, because of 
limitation in preoperative radiological assessment of lung lesions 
smaller than 5 mm. 
We reviewed our series on thoracotomic metastasectomy performed 
for various primary tumors and tried to establish better prognostic 
indicators for its surgical application. 163 patients underwent lung 
metastasectomies from January 2001 to January 2012 in our 
Department. Lung metastases were from colorectal cancer in 75 
patients, renal cells carcinoma in 20, breat in9, gynaecologic tumor in 
17, head and neck cancer in 12, bone and soft tissue sarcoma in 
12,melanoma in 9, hepato and biliary tract in 4 patients. The mean 
disease-free interval (DFI) was 36,9 months. 89 patients had a single-
lung metastasis, 49 oligometastases, 25 multiple metastases.  
The actuarial survival after complete metastasectomy was 83%  at 1 
years, 52%at 5 years and 16% at 10 years.The absence of mediastinal 
lymph node involvement, a limited number of pulmonary metastatic 
lesions, a long disease-free interval, small metastasis, and no 
elevation of tumor markers seem to be prognostic factor in patients 
with pulmonary metastases. The true survival benefits of pulmonary 
metastasectomy remain unclear since there have been no randomized 
trials. However, surgical resection of overt pulmonary metastases can 
render some patients free of disease for long periods. 
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Stereotactic Body Radiotherapy (SBRT) or as it is referred to, 
Stereotactic Ablative Radiotherapy (SABR) has emerged as an 
effective local modality for lung lesions, whether early stage lung 
cancers in medically inoperable patients, or lung metastases from 
other primary tumors. Many series describe the safety and 
effectiveness of lung SBRT – it is well tolerated, convenient for 
patients, non-invasive, and is associated with very mild acute side-
effects, and a low reported rate of significant late effects. The main 
challenges in implementing it for patients with lung metastases lie in 
patient selection, deciding on goals of therapy, and what level of 
evidence is needed to proceed with treatment.  
A rationale approach to offering SBRT for lung metastases is to use the 
same criteria as surgical series, and as documented in the large 
international Lung metastases registry. Patients who are most likely to 
benefit from a radical “curative” approach to their lung metastases 
are those who have no evidence of disease elsewhere, a longer period 
from initial diagnosis to onset of lung metastases, one to max three 
lung metastases and no nodal disease. Critical issues to consider is 
whether this is indeed a metastasis from the previously diagnosed 
extra-thoracic cancer, or possibly a new lung cancer, and what will 
the decision making be once post-SBRT changes on CT scan make the 
assessment of the local control challenging. If the goal of treatment is 
control of the lung lesion with minimal negative quality of life impact, 
then the non-invasive nature of SBRT and low rates of serious side-
effects for peripheral lesions is an attractive consideration.  If 
however the focus is on definitively knowing the status of the lung 
lesions, especially if the patient is fit and a good surgical candidate, 
then the uncertainty of radiological changes post-SBRT is a current 
challenge in managements. Current research will likely shed light on 
this challenge for the future.  For the time being, discussion of 
suitable patients in a multidisciplinary setting, with input from 
treating oncologists and surgical and radiation specialists, and 
education of patients, radiologists and all members of the team to the 
post-SBRT changes will facilitate optimal management of patients, 
while evidence continues to accumulate. 
An interesting question is what evidence should we have in order to 
offer SBRT for patients with lung metastases. Just because we can 
treat lung metastases with SBRT, should we??  An ideal situation would 
be to have high quality data from multiple controlled randomized 
trials, ideally randomizing patients to standard care vs Lung SBRT. An 
immediate question that remains unresolved is what would standard 
care be? Chemotherapy ie systemic therapy alone? No therapy or 
systemic therapy, at the choice of oncologist and patient? Or should 
surgical resection be the control arm?  There are some attempts to 
compare surgical resection to lung SBRT for primary lung cancer, 
although most experts feel that the more pertinent question is 
whether patients (or more likely, which patients) benefit from local 
ablative therapy to their lung metastases. Thus, a randomized study 
of local SBRT therapy vs “management of choice that does not include 
local lung metastases therapy” would be most likely to shed light on 
the benefit of lung SBRT in improving survival, and potentially leading 
to a proportion of patients with lung metastases being cured. Such 
efforts are underway, and will be discussed.  
 PROFFERED PAPERS: PHYSICS 1: IMAGING IN 
RADIOTHERAPY: TECHNICAL DEVELOPMENTS  
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Purpose/Objective: Diffusion weighted magnetic resonance imaging 
(DW-MRI) is a functional imaging technique increasingly used for 
tumor and recurrence diagnosis and response prediction and 
monitoring. Due to the high contrast between tumor and surrounding 
tissue, DW-MRI might be a suitable candidate to facilitate GTV 
definition. However, the use of DW-MRI for tumor delineation in head 
and neck RT is hampered by geometric distortions. These distortions 
are caused by the use of echo planar imaging (EPI) in combination 
with an anatomical region with air/tissue transitions. These 
transitions lead to susceptibility differences and thus magnetic field 
(B0) inhomogeneities. 
The EPI distortions can be estimated by characterizing the magnetic 
field inhomogeneities and the effective spectral width per pixel in the 
EPI sequence [Jezzard 1995]. The aim of this study was to quantify 
geometrical distortion of DW-EPI in head and neck tumors. 
Materials and Methods: In this retrospective study, 27 head and neck 
cancer patients scanned between April 2011 and March 2012 were 
analyzed. For these patients, a B0 map was acquired during standard 
RT treatment planning scans. MR imaging was performed at 3.0T 
(Philips Achieva) and the patients were scanned in an RT 
immobilization mask with Flex-M surface coils. 
MR sequences: B0 map: mDixon 3D T1 FFE; 3-point multi acquisition 
Dixon; ΔTE 1 ms; TR/TE 5.7/2.0 ms; acquired voxel size 2.0 x 2.0 x 2.0 
mm3; FOV 250 x 250 x 150 mm3; acquisition time 0m42s. DW-EPI: 
Single shot SE EPI; EPI factor 43; b-values 0, 150, 800 s/mm2; TR/TE 
3699/66 ms; acquired voxel size 3.0 x 3.0 mm2; slice thickness 3.0 
mm; number of slices 40; FOV 250 x 250 x 120 mm3; SENSE factor 2; 
bandwidth/pixel (phase encode) 35 Hz; acquisition time 2m35s. 
GTVs, as delineated by the radiation oncologist, were retrieved and 
transferred onto the acquired B0 maps (fig 1A). The B0 maps were 
converted to pixel shift maps using the bandwidth per pixel from the 
DW-EPI sequence, which was converted to millimeters using the voxel 
size. Statistical analysis was performed on the displacements within 
these GTVs and the results were averaged over all patients. 
Results:  
 
 
The displacement occurs only in the phase encoding direction of the 
DW-EPI scan, which was AP. Median displacement is relatively small 
because both positive and negative shifts were found. The median 
minimal and maximal displacements were around 1 cm but the 
extremes showed shifts of more than 2 cm (fig 1B). The distortions 
within the GTV can be estimated from the range in displacements. 
Within the GTV a median range of 2 cm was found with a maximum of 
3.5 cm. If the extremes are ignored, still a median range of shifts of 1 
cm was found (fig 1B). The median fraction of the GTV that showed a 
displacement of 6 millimeters (2 voxels) or more was 0.24 (fig 1C). 
Conclusions: Current DW-EPI images in the head and neck area show 
displacements and distortions up to several centimeters which 
severely restricts its usability for GTV delineation in RT treatment 
planning.  
 
 
 
